Peroxisome Proliferator-Activated Receptor γ Agonists Enhance Lung Maturation in a Neonatal Rat Model
暂无分享,去创建一个
Ying Wang | John S Torday | J. Torday | Ying Wang | V. Rehan | R. Sakurai | Jamie Santos | Reiko Sakurai | Eugene Shin | Laura Cerny | Virender K Rehan | L. Cerny | J. Santos | E. Shin | Jamie Santos
[1] J. Auwerx,et al. PPARgamma in human and mouse physiology. , 2007, Biochimica et biophysica acta.
[2] S. Young,et al. Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions. , 1989, The American journal of anatomy.
[3] J. Torday,et al. Developmental Cell/Molecular Biologic Approach to the Etiology and Treatment of Bronchopulmonary Dysplasia , 2007, Pediatric Research.
[4] S. Yao,et al. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia , 2005, Inflammation Research.
[5] B. Spiegelman,et al. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. , 1995, Current opinion in genetics & development.
[6] S. Cuzzocrea,et al. Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] E. Bruce,et al. Dexamethasone-induced changes in lung function are not prevented by concomitant treatment with retinoic acid. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[8] W. H. Hall,et al. Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes , 1995 .
[9] F. Malone,et al. Long-term outcomes after repeat doses of antenatal corticosteroids. , 2007, The New England journal of medicine.
[10] V. Keshamouni,et al. Peroxisome Proliferator-activated Receptor-γ as a Regulator of Lung Inflammation and Repair , 2005 .
[11] J. S. St. Peter,et al. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. , 2002, Diabetes care.
[12] J. Torday,et al. THE ROLE OF FIBROBLAST TRANSDIFFERENTIATION IN LUNG EPITHELIAL CELL PROLIFERATION, DIFFERENTIATION, AND REPAIR IN VITRO , 2003, Pediatric pathology & molecular medicine.
[13] Bethany J Figg,et al. National Institute of Child Health and Human Development , 2013 .
[14] M. Keane,et al. EVIDENCE FOR THE PRESENCE OF LIPOFIBROBLASTS IN HUMAN LUNG , 2006, Experimental lung research.
[15] Thomas J. Mariani,et al. Epithelial cell PPARγ contributes to normal lung maturation , 2006 .
[16] J. Torday,et al. Prevention and Treatment of Bronchopulmonary Dysplasia: Contemporary Status and Future Outlook , 2008, Lung.
[17] Y. Wang,et al. Rosiglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, prevents hyperoxia‐induced neonatal rat lung injury in vivo , 2006, Pediatric pulmonology.
[18] V. Keshamouni,et al. Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair. , 2005, Proceedings of the American Thoracic Society.
[19] P. Sly,et al. Antenatal retinoic acid does not alter alveolization or postnatal lung function in preterm sheep. , 2000, The European respiratory journal.
[20] L. Boros,et al. In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[21] N. Teich,et al. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. , 1985, The Journal of clinical investigation.
[22] Soumyaroop Bhattacharya,et al. Epithelial cell PPAR[gamma] contributes to normal lung maturation. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] E. Mazzon,et al. Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 on bleomycin-induced lung injury , 2005, European Respiratory Journal.
[24] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[25] D. Massaro,et al. Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. , 1986, The American journal of physiology.
[26] J. Auwerx,et al. PPARγ in human and mouse physiology , 2007 .
[27] M. Hanefeld,et al. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. , 2007, The New England journal of medicine.
[28] J. Torday,et al. Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[29] S. Jackson,et al. Perinatal expression of genes that may participate in lipid metabolism by lipid-laden lung fibroblasts. , 1998, Journal of lipid research.
[30] P. Gluckman,et al. Fetal sex and prenatal betamethasone therapy. , 1980, The Journal of pediatrics.